Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HOOK

A Little-Known Gold Miner Just Flashed the Bullish J-Hook Signal

Amid a strengthening case for the fear trade, the precious metals complex potentially offers one of the rare avenues for robust capital gains.

Barchart

Progressive (PGR) Shows That the J-Hook Isn’t Just for Speculation

While Barchart’s J-Hook screener is a useful tool for trading, it can also provide informative entry-point ideas for long-term investments.

Barchart

The best 1910s logos – 10 brilliant designs from the 'Turbulent Decade'

Experts explain why the best 1910s logos have stood the test of time.

Creative Bloq

From analysis to the latest developments in health,
read the most diverse news in one place.

How to watch AEW All In – live stream MJF vs. Adam Cole PPV from anywhere

Here's how to watch an AEW All In live stream from anywhere – as MJF vs. Cole, and Punk vs. Joe headline. Start time, TV channel, All In card, wrestlers and expert analysis.

TechRadar

HOOKIPA Pharma's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million.

Benzinga

Hookipa Shares Jump On New Preclinical Data On Cancer Immunotherapies

HOOKIPA Pharma Inc (NASDAQ: HOOK) has

Benzinga

HOOKIPA Pharma's Return On Capital Employed Overview

Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

HOOKIPA Pharma: Q4 Earnings Insights

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings

Benzinga

HOOKIPA Pharma Earnings Preview

HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that HOOKIPA Pharma will report an earnings per share (EPS) of $-0.58.

Benzinga

How To Attend HOOKIPA Pharma Q4 2021 Earnings Conference Call

HOOKIPA Pharma (NASDAQ:HOOK) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend HOOKIPA Pharma (HOOK) Conference Call Follow this link to access the live webcast.

Benzinga

Hookipa Pharma Stock Surges On HIV Pact With Gilead

Hookipa Pharma Inc (NASDAQ: HOOK)

Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

Here's a roundup of top developments in the biotech space over the last 24 hours.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.